ORANGE PHARMA LIMITED

🇬🇧United Kingdom•Private Limited Company (Ltd.)•Proposal to strike off

Equity ratio (2018)Equity ratio

100%

YoY total assets (2022 vs 2023)YoY total assets

+69.6%

YoY net current assets (2022 vs 2023)YoY net current assets

Summary

CountryUnited Kingdom

StatusProposal to strike off

Registration Number05542879

Founded22/08/2005

PurposeNon-specialised wholesale trade

AddressAmbe House, Commerce Way, Edenbridge, Kent, TN8 6ED

Confirmation StatementNext due: 05/09/2025; Last made up: 22/08/2024

Legal & Status

Legal FormPrivate Limited Company (Ltd.)

StatusProposal to strike off

Registration Date22/08/2005

Registry AuthorityCompanies House

Registered Capital—

Source: UK Companies House · Last updated: 02/12/2025

Timeline (9 events)

01/03/2025

Status changed

active → active - proposal to strike off

31/03/2023

Annual accounts filed

Annual Accounts · Accounting year ending 31/03/2023

View file in Documents

22/08/2005

Company incorporated

Incorporation date: 2005-08-22

Metric	2018	2019	2020	2021	2022	2023
Total assets	£13,680	£-22,972	£-25,506	£-25,506	£-25,506	£-7,761
Net Assets Liabilities	£13,680	£-22,972	£-25,506	£-25,506	£-25,506	£-7,761
Equity	£13,680	£-22,972	£-25,506	£-25,506	£-25,506	£-7,761
Current Assets	£1,510,534	£86,119	£85,445	£85,446	£85,446	£1,105
Net Current Assets Liabilities	£13,680	£-22,972	£-25,506	£-25,506	£-25,506	£-7,761
Total Assets Less Current Liabilities	£13,680	£-22,972	£-25,506	£-25,506	£-25,506	£-7,761
Cash Bank On Hand	£3,413	£1,778	£1,105	£1,105	£1,105	£1,105
Debtors	£1,507,121	£84,341	£84,341	£84,341	£84,341	—
Other Debtors	£1,451,711	£84,341	£84,341	£84,341	£84,341	—
Creditors	£1,496,854	£109,091	£110,951	£110,952	£110,952	£8,866
Trade Creditors Trade Payables	£9,907	£1,342	—	—	—	—
Other Creditors	£1,472,139	£98,655	£102,085	£102,085	£102,085	—
Average Number Employees During Period	1	—	1	1	1	1
Accrued Liabilities Deferred Income	£1,335	£1,320	£1,075	£1,075	£1,075	£1,075
Balances Amounts Owed By Related Parties	£-40,428	—	—	—	—	—
Balances Amounts Owed To Related Parties	£15,000	—	—	—	—	—
Bank Overdrafts	—	£18	£18	£18	£18	£18
Cash Cash Equivalents	—	£1,778	£1,087	£1,087	£1,087	£1,087
Other Taxation Social Security Payable	£13,473	£7,774	—	—	—	—
Taxation Social Security Payable	—	—	£7,773	£7,774	£7,774	£7,773
Trade Debtors Trade Receivables	£55,410	—	—	—	—	—

Metric

2018

2019

2020

2021

2022

2023

Total assets

£13,680

£-22,972

£-25,506

£-7,761

Net Assets Liabilities

£13,680

£-22,972

£-25,506

£-7,761

Equity

£13,680

£-22,972

£-25,506

£-7,761

Current Assets

£1,510,534

£86,119

£85,445

£85,446

£1,105

Net Current Assets Liabilities

£13,680

£-22,972

£-25,506

£-7,761

Total Assets Less Current Liabilities

£13,680

£-22,972

£-25,506

£-7,761

Cash Bank On Hand

£3,413

£1,778

£1,105

Debtors

£1,507,121

£84,341

—

Other Debtors

£1,451,711

£84,341

—

Creditors

£1,496,854

£109,091

£110,951

£110,952

£8,866

Trade Creditors Trade Payables

£9,907

£1,342

—

Other Creditors

£1,472,139

£98,655

£102,085

—

Average Number Employees During Period

—

Accrued Liabilities Deferred Income

£1,335

£1,320

£1,075

Balances Amounts Owed By Related Parties

£-40,428

—

Balances Amounts Owed To Related Parties

£15,000

—

Bank Overdrafts

—

£18

Cash Cash Equivalents

—

£1,778

£1,087

Other Taxation Social Security Payable

£13,473

£7,774

—

Taxation Social Security Payable

—

£7,773

£7,774

£7,773

Trade Debtors Trade Receivables

£55,410

—

Name	Holding	Voting	Since

Name	Ownership	Country	Since

ORANGE PHARMA LIMITED

Summary

Legal & Status

Timeline (9 events)

Status changed

Annual accounts filed

Company incorporated

Network

Ownership & Management

Persons with significant control

Ownership Timeline (1 changes)

Appointed Chetas Patel (person)

Shareholders

Ultimate Beneficial Owner

Geography

Financials

Key figures

Documents

Company Report of ORANGE PHARMA LIMITED

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Browse more companies & persons

Financial Health

Growth

Working capital & liquidity

Capital structure